Sort
17,828 grants matching “crispr”
Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens
$698,106Danwei Huangfu · Sloan-Kettering Inst Can Research · U01 · FY2023 · DK
Characterizing non-coding somatic and germline variant interactions in ovarian cancer
$698,082Simon Andrew Gayther · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
$698,064Richard A Oberhelman · Tulane University Of Louisiana · R01 · FY2024 · AI
Integration of functional data and GWAS to elucidate genetic basis of diseases
$698,013Jonathan K Pritchard · Stanford University · R01 · FY2020 · HG
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$697,654Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Center for Cell-based Therapy - Cures
$697,518Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Advanced analytics for uncovering virus dynamics and functional potential
$697,412Nikos C Kyrpides · University Of Calif-Lawrenc Berkeley Lab · U01 · FY2025 · DE
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2024 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2025 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2023 · AI
Defining the Biology of the ADAR1-RISC Complex
$697,404Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2022 · AI
c-Myc Function
$697,337David Levens · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
$697,256Thomas E Lane · University Of California-Irvine · R35 · FY2020 · NS
Developing gene therapy strategies to treat alpha thalassemia
$697,241Tippi Mackenzie · University Of California, San Francisco · R01 · FY2025 · HL
Non-canonical epitope presentation and antigen processing by MHC-E
$697,170Klaus J Frueh · Oregon Health & Science University · R01 · FY2025 · AI
Precision mapping of regulatory causal variants by expression CROPseq
$697,161Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2022 · HG
Precision mapping of regulatory causal variants by expression CROPseq
$696,862Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2023 · HG
Functional characterization of schizophrenia rare variants using genetically engineered human iPSCs
$696,676Pan Li · Johns Hopkins University · R01 · FY2023 · MH
CRISPR EXCISION AND LONG-READ SEQUENCING OF BRCA1 AND BRCA2 TO IDENTIFY PREVIOUSLY UNDETECTABLE CLASSES OF MUTATIONS IN FAMILIES WITH OVARIAN CANCER
$696,616University Of Washington · · FY2020 · Defense Health Agency
Targeting LCN2, a novel therapy for lung cancer
$696,569Thales Papagiannakopoulos · New York University School Of Medicine · R01 · FY2025 · CA
Biophysical and genetic approaches to uncover ventral disc contractile attachment mechanisms in Giardia
$696,544Scott C Dawson · University Of California At Davis · R01 · FY2025 · AI
Genetic and Proteomic Approaches to Reveal Bacterial Vulnerabilities to Phage Predation
$696,467Joseph Bondy-Denomy · University Of California, San Francisco · R01 · FY2025 · AI
Human adipose tissue in control of sympathetic tone and metabolic rate
$696,393Silvia Corvera · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · DK
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing
$696,272Katharine June Bar · University Of Pennsylvania · R01 · FY2025 · MH
Understanding and targeting molecular and cellular events responsible for pulmonary arteriovenous malformation development, growth and regression
$696,236Edda Frauke Spiekerkoetter · Stanford University · R01 · FY2023 · HL